A Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer|Tumor, Solid|Advanced Solid Tumor|Metastatic Cancer|Melanoma|Colorectal Cancer|Breast Cancer
Interventions: DRUG: JK08
Sponsor: Salubris Biotherapeutics Inc